Genetics of narcolepsy and other sleep disorders.

Por Mignot, E
Publicado em 1997

Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy.

Por Nishino, S, Mignot, E, Fruhstorfer, B, Dement, W C, Hayaishi, O
Publicado em 1989

Role of central alpha-1 adrenoceptors in canine narcolepsy.

Por Mignot, E, Guilleminault, C, Bowersox, S, Rappaport, A, Dement, W C
Publicado em 1988

Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis

Por Overeem, S., Dalmau, J., Bataller, L., Nishino, S., Mignot, E., Verschuuren, J., Lammers, G.J.
Publicado em 2004

Effects of sleep on the cardiovascular and thermoregulatory systems: a possible role for hypocretins

Por Schwimmer, H., Stauss, H. M., Abboud, F., Nishino, S., Mignot, E., Zeitzer, J. M.
Publicado no J Appl Physiol (1985) (2010)

Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy

Por Honda, M, Arai, T, Fukazawa, M, Honda, Y, Tsuchiya, K, Salehi, A, Akiyama, H, Mignot, E
Publicado em 2009

Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment.

Por Mignot, E, Wang, C, Rattazzi, C, Gaiser, C, Lovett, M, Guilleminault, C, Dement, W C, Grumet, F C
Publicado em 1991

Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial

Por Blackman, A, Foster, G D, Zammit, G, Rosenberg, R, Aronne, L, Wadden, T, Claudius, B, Jensen, C B, Mignot, E
Publicado no Int J Obes (Lond) (2016)